Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 638

1.

The utility of procalcitonin in critically ill trauma patients.

Sakran JV, Michetti CP, Sheridan MJ, Richmond R, Waked T, Aldaghlas T, Rizzo A, Griffen M, Fakhry SM.

J Trauma Acute Care Surg. 2012 Aug;73(2):413-8; discussion 418. doi: 10.1097/TA.0b013e31825ff5b7.

PMID:
22846948
2.

Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis.

Garnacho-Montero J, Huici-Moreno MJ, Gutiérrez-Pizarraya A, López I, Márquez-Vácaro JA, Macher H, Guerrero JM, Puppo-Moreno A.

Crit Care. 2014 Jun 5;18(3):R116. doi: 10.1186/cc13908.

3.

Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage.

Oconnor E, Venkatesh B, Mashongonyika C, Lipman J, Hall J, Thomas P.

Anaesth Intensive Care. 2004 Aug;32(4):465-70.

4.

[Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection].

Yu X, Ma X, Ai Y.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jun;27(6):477-83. doi: 10.3760/cma.j.issn.2095-4352.2015.06.012. Chinese.

5.

[Significance of serum procalcitonin levels in the evaluation of severity and prognosis of patients with systemic inflammatory response syndrome].

Huang WP, Jiang WQ, Hu B, Ye H, Zeng HK.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 May;24(5):294-7. Chinese.

6.

[Changes in plasma interleukin-33 concentration in sepsis and its correlation with seriousness of sepsis].

Chang D, Jia J, Zang B.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Feb;27(2):138-42. doi: 10.3760/cma.j.issn.2095-4352.2015.02.012. Chinese.

7.

Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?

Iapichino G, Marzorati S, Umbrello M, Baccalini R, Barassi A, Cainarca M, Colombo Pavini F, Mantovani E, Mauri A, Moroni B, Noto A, Melzi D'Eril GV, Langer M.

Minerva Anestesiol. 2010 Oct;76(10):814-23. Epub 2010 Jul 1.

8.

Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients.

Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W.

Crit Care Med. 2000 Apr;28(4):950-7.

PMID:
10809265
10.

Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.

Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L.

Crit Care. 2004 Aug;8(4):R234-42. Epub 2004 Jun 10.

11.

[The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].

Ma J, Wang S, Chen D, Duan J, Li C, Li G.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Aug;28(8):688-93. doi: 10.3760/cma.j.issn.2095-4352.2016.08.004. Chinese.

12.
13.

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.

Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R.

Intensive Care Med. 2000 Mar;26 Suppl 2:S148-52. doi: 10.1007/BF02900728.

PMID:
18470710
14.

[Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome].

Liu XL, Du B, Pan JQ, Xu Y, Hua BL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):48-52. Chinese.

PMID:
15782493
15.

Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response.

Tugrul S, Esen F, Celebi S, Ozcan PE, Akinci O, Cakar N, Telci L.

Anaesth Intensive Care. 2002 Dec;30(6):747-54.

16.

[The value of pro-adrenomedullin in early diagnosis of sepsis].

Yan L, Cailan L, Hong L, Zheng L, Wei D.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Sep;27(9):739-42. Chinese.

17.

[Usefulness of procalcitonin upon admission to intensive care in the diagnosis and prognosis of sepsis].

Moretti D, Ramírez MM, Settecase CJ, Bagilet DH, Quaglino MB.

Med Intensiva. 2013 Apr;37(3):156-62. doi: 10.1016/j.medin.2012.03.018. Epub 2012 Jun 2. Spanish.

18.

Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study.

Anand D, Das S, Bhargava S, Srivastava LM, Garg A, Tyagi N, Taneja S, Ray S.

J Crit Care. 2015 Feb;30(1):218.e7-12. doi: 10.1016/j.jcrc.2014.08.017. Epub 2014 Sep 6.

PMID:
25263339
19.

Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.

Shehabi Y, Sterba M, Garrett PM, Rachakonda KS, Stephens D, Harrigan P, Walker A, Bailey MJ, Johnson B, Millis D, Ding G, Peake S, Wong H, Thomas J, Smith K, Forbes L, Hardie M, Micallef S, Fraser JF; ProGUARD Study Investigators; ANZICS Clinical Trials Group.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):1102-10. doi: 10.1164/rccm.201408-1483OC.

PMID:
25295709
20.

Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.

Liu B, Chen YX, Yin Q, Zhao YZ, Li CS.

Crit Care. 2013 Oct 20;17(5):R244. doi: 10.1186/cc13070.

Supplemental Content

Support Center